Charles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Trimmed by KBC Group NV

KBC Group NV lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 37.3% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 84,566 shares of the medical research company’s stock after selling 50,319 shares during the quarter. […]

Leave a Reply

Your email address will not be published.

Previous post Plato Investment Management Ltd Has $40,000 Stake in Core & Main, Inc. (NYSE:CNM)
Next post NFL Notes: The untold secret behind the Patriots’ Super Bowl LIII win over the Rams